Ordeniza, Rafael F.
HRN: 21-73-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/13/2022
IVT
400mg
Q8 X 7 Days
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes